Johann Brandes, MD,PhD, FCCP
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Ludwig Maximilian University of Munich Faculty of Medicine
Medical School
Johns Hopkins University
Residency
Johns Hopkins University
Fellowship
American Board of Internal Medicine - Oncology
TN State Medical License: 2014 - 2017
GA State Medical License: 2009 - 2016
MD State Medical License: 2003 - 2016
American Board of Internal Medicine: Medical Oncology
American Board of Internal Medicine: Critical Care Medicine
American Board of Internal Medicine: Pulmonary Disease
American Board of Internal Medicine: Internal Medicine
Saint Thomas - Rutherford Hospital
Languages: English/Spanish
(615) 396-4100
1700 Medical Center Pkwy
Read MoreSmall molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer.
Brodie SA, Li G, Harvey D, Khuri FR, Vertino PM, Brandes JC; Oncotarget. 2015 Oct 13.
See more >>Class I HDACs are mediators of smoke-carcinogen induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.
Brodie SA Li G El-Kommos A Kang H Ramalingam SS Behera M Gandhi K Kowalski J Sica GL Khuri FR Vertino PM Brandes JC; Cancer Prev Res (Phila). 2014 Jan 17 .
See more >>Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
Brodie SA Li G Brandes JC; Respir Med. 2014 Nov 21 .
See more >>